Arcutis Biotherapeutics develops topical therapies for chronic skin conditions, with a portfolio targeting psoriasis and atopic dermatitis.On February 5, Tejara Capital reported selling out of Arcutis Biotherapeutics (ARQT 0.04%), unloading 520,503 shares in an estimated $9.81 million trade based on quarterly average pricing.What happenedAccording to a U.S. Securities and Exchange Commission (SEC) filing dated February 5, Tejara Capital reported selling its entire holding of 520,503 shares in Arcutis Biothe ...

On February 2, Tweedy, Browne Co disclosed in an SEC filing that it sold 31,740 shares of Autoliv (NYSE:ALV), an estimated $3.79 million trade based on quarterly average pricing. What happened In an SEC filing dated February 2, Connecticut-based financial planner Tweedy, Browne reported selling 31,740 shares of Autoliv during the fourth quarter. The estimated transaction value was $3.79 million, calculated using the average unadjusted closing price for the period. The reduction brought the stake to 400,9 ...